Free Trial
NASDAQ:KRON

Kronos Bio (KRON) Stock Price, News & Analysis

Kronos Bio logo
$0.88 +0.01 (+1.49%)
As of 06/20/2025
This is a fair market value price provided by Polygon.io. Learn more.

About Kronos Bio Stock (NASDAQ:KRON)

Key Stats

Today's Range
$0.87
$0.88
50-Day Range
$0.67
$0.89
52-Week Range
$0.65
$1.46
Volume
54,089 shs
Average Volume
367,836 shs
Market Capitalization
$53.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.63
Consensus Rating
Hold

Company Overview

Receive KRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kronos Bio and its competitors with MarketBeat's FREE daily newsletter.

KRON Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
Kronos Bio sends Cambridge lab space back to market
Concentra To Acquire Kronos Bio
See More Headlines

KRON Stock Analysis - Frequently Asked Questions

Kronos Bio's stock was trading at $0.95 at the beginning of 2025. Since then, KRON stock has decreased by 7.4% and is now trading at $0.88.

Kronos Bio, Inc. (NASDAQ:KRON) posted its quarterly earnings data on Tuesday, March, 18th. The company reported ($0.43) earnings per share for the quarter, missing analysts' consensus estimates of ($0.30) by $0.13. The company earned $2.27 million during the quarter, compared to the consensus estimate of $1 million. Kronos Bio had a negative trailing twelve-month return on equity of 64.22% and a negative net margin of 701.53%.

Kronos Bio (KRON) raised $175 million in an initial public offering on Friday, October 9th 2020. The company issued 10,300,000 shares at $16.00-$18.00 per share. Goldman Sachs, Jefferies, Cowen and Piper Sandler acted as the underwriters for the IPO.

Shares of KRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kronos Bio investors own include Bank of America (BAC), AT&T (T), Taseko Mines (TGB), Energy Transfer (ET), ARMOUR Residential REIT (ARR), Prospect Capital (PSEC) and New Gold (NGD).

Company Calendar

Last Earnings
3/18/2025
Today
7/18/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:KRON
CIK
1741830
Fax
N/A
Employees
100
Year Founded
N/A

Price Target and Rating

High Price Target
$2.25
Low Price Target
$1.00
Potential Upside/Downside
+84.7%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$86.08 million
Net Margins
-701.53%
Pretax Margin
-701.53%
Return on Equity
-64.22%
Return on Assets
-47.17%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.93
Quick Ratio
12.93

Sales & Book Value

Annual Sales
$9.85 million
Price / Sales
5.45
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.45 per share
Price / Book
0.61

Miscellaneous

Outstanding Shares
61,050,000
Free Float
46,155,000
Market Cap
$53.72 million
Optionable
Optionable
Beta
1.64
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:KRON) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners